Notably, many lines of evidence indicate that oncogenic BRAF can stimulate pro-survival autophagy in different tumor models [17,18,19] and that the autophagic process can exert a cytoprotective function against Vemurafenib-induced cell death in BRAF-mutated tumors, including melanoma [20,21,22,23]. Here, BRAF is linked to melanoma.